Product Name :
DMAT
Description:
DMAT is a potent and specific CK2 inhibitor with an IC50 value of 130 nM.
CAS:
749234-11-5
Molecular Weight:
476.79
Formula:
C9H7Br4N3
Chemical Name:
DMAT
Smiles :
CN(C)C1NC2=C(N=1)C(Br)=C(Br)C(Br)=C2Br
InChiKey:
SLPJGDQJLTYWCI-UHFFFAOYSA-N
InChi :
InChI=1S/C9H7Br4N3/c1-16(2)9-14-7-5(12)3(10)4(11)6(13)8(7)15-9/h1-2H3,(H,14,15)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Pralsetinib} site|{Pralsetinib} RET|{Pralsetinib} Technical Information|{Pralsetinib} References|{Pralsetinib} manufacturer|{Pralsetinib} Autophagy}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
DMAT is a potent and specific CK2 inhibitor with an IC50 value of 130 nM.|Product information|CAS Number: 749234-11-5|Molecular Weight: 476.79|Formula: C9H7Br4N3|Synonym:|CK2 Inhibitor|Casein kinase II Inhibitor|Chemical Name: DMAT|Smiles: CN(C)C1NC2=C(N=1)C(Br)=C(Br)C(Br)=C2Br|InChiKey: SLPJGDQJLTYWCI-UHFFFAOYSA-N|InChi: InChI=1S/C9H7Br4N3/c1-16(2)9-14-7-5(12)3(10)4(11)6(13)8(7)15-9/h1-2H3,(H,14,15)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 50 mg/mL (104.87 mM; Need ultrasonic)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined.|HS Tariff Code: 382200|How to use|In Vitro:|DMAT (1 μM-2.5 μM) DMAT is more efficient in killing antiestrogen resistant cells than parental antiestrogen sensitive MCF-7 cells. DMAT-induced cell death of antiestrogen resistant cells is mediated by caspases. DMAT inhibits CK2 activity but the inhibition is similar in the three cell lines, MCF-7, TAMR-1 and 182R-6[1]. DMAT has effects on H295R cell proliferation at concentrations of 10-4 and 10-5mol/Las compared with the control. DMAT (100 μM) significantly increases apoptosis of H295R cells. DMAT (1 nM-1 μM) significantly decreases aldosterone release into supernatants of 72-h H295R cell cultures as compared with the control. DMAT also inhibits PIM1 by a mechanism which is competitive with respect to ATP, and it is a powerful inhibitor of kinases other than CK2.|In Vivo:|DMAT application in vivo reduces tumor growth in a xenotransplant model by interference with tumor cell proliferation.{{Epoprostenol} MedChemExpress|{Epoprostenol} Endogenous Metabolite|{Epoprostenol} Purity & Documentation|{Epoprostenol} Description|{Epoprostenol} custom synthesis|{Epoprostenol} Autophagy} Biochemical parameters and histology following DMAT administration revealed no alterations in liver tissue.PMID:23376608 |References:|Yde CW, et al. Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitorDMAT. Cancer Lett. 2007 Oct 28;256(2):229-37.Lawnicka H, et al. Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro. Cell Tissue Res. 2010 May;340Pagano MA, et al. The selectivity of inhibitors of protein kinase CK2: an update. Biochem J. 2008 Nov 1;415(3):353-65.Sass G, et al. Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT. Int J Oncol. 2011 Aug;39(2):433-42.Products are for research use only. Not for human use.|
